Study: Drugs as good as stents

Score another point for drug therapy over stents. A new report shows that patients with chest pain but no emergency heart troubles do just as well on drugs as they would with implanted stents. Angioplasty did have a slight advantage on pain relief at first, but that shrank after six months and disappeared within three years.

This could be good news for patients--who wouldn't have to go through the procedure--along with payers, who have to shell out some $40,000 for angioplasty. Not to mention drugmakers. "This study should be enlightening and practice-changing," leading more to try drugs before stents, said Duke's Dr. Eric Peterson, who co-authored an editorial in the New England Journal of Medicine about the report.

- read the story in the Washington Post

Suggested Articles

Despite having lost some of its novelty, AZ's Brilinta is touting bleeding data over aspirin that could be a big break in acute coronary syndrome.

More than a year after J&J and Bayer pulled the plug on Xarelto in patients after a rare valve replacement, the pair are still seeking answers.

Having already whiffed on one crucial heart failure trial, Novartis is focusing on "profound" data from its Entresto studies in hopes for another go.